TISSUE ROBERT S 4

What Happened

• Robert S. Tissue, Executive Vice President, Financial Strategy of Burke & Herbert Financial Services Corp. (BHRB), was awarded 3,080 performance-based restricted stock units (PRSUs) on 2026-01-22. The award was reported as an acquisition at $0.00 (grant), so no cash was paid by the insider.

Key Details

• Transaction date: 2026-01-22; Form 4 filed 2026-01-23.
• Transaction type/code: Award/Grant (A).
• Amount: 3,080 PRSUs granted; reported acquisition price $0.00 (grant value recorded as $0 on Form 4).
• Vesting: Awards vest in three annual installments beginning May 3, 2026, subject to continued employment through each vesting date.
• Settlement: Each vested PRSU will be settled in shares of BHRB common stock within 60 days after the applicable vest date.
• Shares owned after transaction: Not specified in the Form 4 filing.
• Timeliness: Filing appears timely (transaction reported the next day); no late-filing flag noted.

Context

• PRSUs are conditional awards that convert to company shares only if time/service (and potentially performance) conditions are met; they are not an immediate purchase of stock. Such grants are common compensation for executives and do not by themselves indicate a buy or sell market signal until vested shares are delivered or sold.